Old Web
English
Sign In
Acemap
>
Paper
>
1296P BLU-945, a highly potent and selective 4th generation EGFR TKI for the treatment of EGFR T790M/C797S resistant NSCLC
1296P BLU-945, a highly potent and selective 4th generation EGFR TKI for the treatment of EGFR T790M/C797S resistant NSCLC
2020
S.S. Schalm
T Dineen
S.-M. Lim
C. W. Park
J. Hsieh
R Woessner
Z Zhang
K Wilson
M Eno
D. Wilson
B Williams
J. Campbell
C. De Savi
F. Stevison
C. Utt
T. Guzi
Marion Dorsch
K. Hoeflich
B.C. Chul Cho
Keywords:
Cancer research
egfr tki
EGFR T790M
Medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
12
Citations
NaN
KQI
[]